Fabrication and functional characterization of goldnanoconjugates for potential application in ovarian cancer

Chitta Ranjan Patra, Resham Bhattacharya, Priyabrata Mukherjee

Research output: Contribution to journalArticle

70 Citations (Scopus)

Abstract

In this paper we report the surface modification and functional characterization of a gold nanoparticle-based drug delivery system for potential therapeutic application in ovarian cancer. It is currently recognized that nanotechnology may play a pivotal role in drug delivery by increasing efficacy and reducing toxicity of anticancer drugs. Here, we report the fabrication of a gold nanoparticle (AuNP) based drug delivery system consisting of folic acid (FA), mercapto-polyethylene glycol (PEG-SH) with a molecular weight of 2000 (designated as PSH2-2 K or PSH) and cis-platin (CP) [Au-PSH-CP-FA] for potential therapeutic application in ovarian cancer. Fabrication is done in a three step incubation process at room temperature (RT). The gold nanoconjugates are characterized with several physico-chemical techniques such as UV-Vis (UV-visible spectroscopy), TEM (transmission electron microscopy), ICP (inductively coupled plasma) and radioactivity measurement with a scintillation counter. Attachment and release profiles of FA from the gold nanoconjugates are performed using 3H-labelled FA (3H-FA). The expressions of folate receptor (FR) for ovarian cancer cell lines (OV-167, OVCAR-5), human umbilical vein endothelial cells (HUVEC) and ovarian surface epithelial (OSE) cells are determined by FACS analysis. Quantitation of platinum content in the nanoconjugates and its release profile is determined by platinum (Pt) analysis using ICP-MS. Biological functional characterization using in vitro proliferation assay demonstrates that Au-PSH-CP-FA not only retains the cytotoxic effect of CP, but it protects the normal cells from the cytotoxic insult, while enhancing the cytotoxic effect on the tumor cells. In future, this strategy may be utilized as a strategy for the treatment of ovarian cancers and may overcome the core side effect issues in anticancer therapy.

Original languageEnglish (US)
Pages (from-to)547-554
Number of pages8
JournalJournal of Materials Chemistry
Volume20
Issue number3
DOIs
StatePublished - 2010

Fingerprint

Nanoconjugates
Folic Acid
Fabrication
Gold
Acids
Inductively coupled plasma
Polyethylene glycols
Platinum
Radioactivity measurement
Cells
Nanoparticles
Scintillation counters
Endothelial cells
Drug delivery
Nanotechnology
Toxicity
Surface treatment
Tumors
Assays
Molecular weight

ASJC Scopus subject areas

  • Materials Chemistry
  • Chemistry(all)

Cite this

Fabrication and functional characterization of goldnanoconjugates for potential application in ovarian cancer. / Patra, Chitta Ranjan; Bhattacharya, Resham; Mukherjee, Priyabrata.

In: Journal of Materials Chemistry, Vol. 20, No. 3, 2010, p. 547-554.

Research output: Contribution to journalArticle

Patra, Chitta Ranjan ; Bhattacharya, Resham ; Mukherjee, Priyabrata. / Fabrication and functional characterization of goldnanoconjugates for potential application in ovarian cancer. In: Journal of Materials Chemistry. 2010 ; Vol. 20, No. 3. pp. 547-554.
@article{7cc6163c699b447b912844ffd5d2593d,
title = "Fabrication and functional characterization of goldnanoconjugates for potential application in ovarian cancer",
abstract = "In this paper we report the surface modification and functional characterization of a gold nanoparticle-based drug delivery system for potential therapeutic application in ovarian cancer. It is currently recognized that nanotechnology may play a pivotal role in drug delivery by increasing efficacy and reducing toxicity of anticancer drugs. Here, we report the fabrication of a gold nanoparticle (AuNP) based drug delivery system consisting of folic acid (FA), mercapto-polyethylene glycol (PEG-SH) with a molecular weight of 2000 (designated as PSH2-2 K or PSH) and cis-platin (CP) [Au-PSH-CP-FA] for potential therapeutic application in ovarian cancer. Fabrication is done in a three step incubation process at room temperature (RT). The gold nanoconjugates are characterized with several physico-chemical techniques such as UV-Vis (UV-visible spectroscopy), TEM (transmission electron microscopy), ICP (inductively coupled plasma) and radioactivity measurement with a scintillation counter. Attachment and release profiles of FA from the gold nanoconjugates are performed using 3H-labelled FA (3H-FA). The expressions of folate receptor (FR) for ovarian cancer cell lines (OV-167, OVCAR-5), human umbilical vein endothelial cells (HUVEC) and ovarian surface epithelial (OSE) cells are determined by FACS analysis. Quantitation of platinum content in the nanoconjugates and its release profile is determined by platinum (Pt) analysis using ICP-MS. Biological functional characterization using in vitro proliferation assay demonstrates that Au-PSH-CP-FA not only retains the cytotoxic effect of CP, but it protects the normal cells from the cytotoxic insult, while enhancing the cytotoxic effect on the tumor cells. In future, this strategy may be utilized as a strategy for the treatment of ovarian cancers and may overcome the core side effect issues in anticancer therapy.",
author = "Patra, {Chitta Ranjan} and Resham Bhattacharya and Priyabrata Mukherjee",
year = "2010",
doi = "10.1039/b913224d",
language = "English (US)",
volume = "20",
pages = "547--554",
journal = "Journal of Materials Chemistry",
issn = "0959-9428",
publisher = "Royal Society of Chemistry",
number = "3",

}

TY - JOUR

T1 - Fabrication and functional characterization of goldnanoconjugates for potential application in ovarian cancer

AU - Patra, Chitta Ranjan

AU - Bhattacharya, Resham

AU - Mukherjee, Priyabrata

PY - 2010

Y1 - 2010

N2 - In this paper we report the surface modification and functional characterization of a gold nanoparticle-based drug delivery system for potential therapeutic application in ovarian cancer. It is currently recognized that nanotechnology may play a pivotal role in drug delivery by increasing efficacy and reducing toxicity of anticancer drugs. Here, we report the fabrication of a gold nanoparticle (AuNP) based drug delivery system consisting of folic acid (FA), mercapto-polyethylene glycol (PEG-SH) with a molecular weight of 2000 (designated as PSH2-2 K or PSH) and cis-platin (CP) [Au-PSH-CP-FA] for potential therapeutic application in ovarian cancer. Fabrication is done in a three step incubation process at room temperature (RT). The gold nanoconjugates are characterized with several physico-chemical techniques such as UV-Vis (UV-visible spectroscopy), TEM (transmission electron microscopy), ICP (inductively coupled plasma) and radioactivity measurement with a scintillation counter. Attachment and release profiles of FA from the gold nanoconjugates are performed using 3H-labelled FA (3H-FA). The expressions of folate receptor (FR) for ovarian cancer cell lines (OV-167, OVCAR-5), human umbilical vein endothelial cells (HUVEC) and ovarian surface epithelial (OSE) cells are determined by FACS analysis. Quantitation of platinum content in the nanoconjugates and its release profile is determined by platinum (Pt) analysis using ICP-MS. Biological functional characterization using in vitro proliferation assay demonstrates that Au-PSH-CP-FA not only retains the cytotoxic effect of CP, but it protects the normal cells from the cytotoxic insult, while enhancing the cytotoxic effect on the tumor cells. In future, this strategy may be utilized as a strategy for the treatment of ovarian cancers and may overcome the core side effect issues in anticancer therapy.

AB - In this paper we report the surface modification and functional characterization of a gold nanoparticle-based drug delivery system for potential therapeutic application in ovarian cancer. It is currently recognized that nanotechnology may play a pivotal role in drug delivery by increasing efficacy and reducing toxicity of anticancer drugs. Here, we report the fabrication of a gold nanoparticle (AuNP) based drug delivery system consisting of folic acid (FA), mercapto-polyethylene glycol (PEG-SH) with a molecular weight of 2000 (designated as PSH2-2 K or PSH) and cis-platin (CP) [Au-PSH-CP-FA] for potential therapeutic application in ovarian cancer. Fabrication is done in a three step incubation process at room temperature (RT). The gold nanoconjugates are characterized with several physico-chemical techniques such as UV-Vis (UV-visible spectroscopy), TEM (transmission electron microscopy), ICP (inductively coupled plasma) and radioactivity measurement with a scintillation counter. Attachment and release profiles of FA from the gold nanoconjugates are performed using 3H-labelled FA (3H-FA). The expressions of folate receptor (FR) for ovarian cancer cell lines (OV-167, OVCAR-5), human umbilical vein endothelial cells (HUVEC) and ovarian surface epithelial (OSE) cells are determined by FACS analysis. Quantitation of platinum content in the nanoconjugates and its release profile is determined by platinum (Pt) analysis using ICP-MS. Biological functional characterization using in vitro proliferation assay demonstrates that Au-PSH-CP-FA not only retains the cytotoxic effect of CP, but it protects the normal cells from the cytotoxic insult, while enhancing the cytotoxic effect on the tumor cells. In future, this strategy may be utilized as a strategy for the treatment of ovarian cancers and may overcome the core side effect issues in anticancer therapy.

UR - http://www.scopus.com/inward/record.url?scp=72949117416&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=72949117416&partnerID=8YFLogxK

U2 - 10.1039/b913224d

DO - 10.1039/b913224d

M3 - Article

AN - SCOPUS:72949117416

VL - 20

SP - 547

EP - 554

JO - Journal of Materials Chemistry

JF - Journal of Materials Chemistry

SN - 0959-9428

IS - 3

ER -